Literature DB >> 22239616

Fluorescent peptide-PNA chimeras for imaging monoamine oxidase A mRNA in neuronal cells.

Dalip Sethi1, Chang-Po Chen, Rui-Yan Jing, Mathew L Thakur, Eric Wickstrom.   

Abstract

Monoamine oxidases (MAO) catalyze the oxidative deamination of many biogenic amines and are integral proteins found in the mitochondrial outer membrane. Changes in MAO-A levels are associated with depression, trait aggression, and addiction. Here we report the synthesis, characterization, and in vitro evaluation of novel fluorescent peptide-peptide nucleic acid (PNA) chimeras for MAOA mRNA imaging in live neuronal cells. The probes were designed to include MAOA-specific PNA dodecamers, separated by an N-terminal spacer to a μ-opioid receptor targeting peptide (DAMGO), with a spacer and a fluorophore on the C-terminus. The probe was successfully delivered into human SH-SY5Y neuroblastoma cells through μ-opioid receptor-mediated endocytosis. The K(d) by flow cytometry was 11.6 ± 0.8 nM. Uptake studies by fluorescence microscopy showed ∼5-fold higher signal in human SH-SY5Y neuroblastoma cells than in negative control CHO-K1 cells that lack μ-opioid receptors. Moreover, a peptide-mismatch control sequence showed no significant uptake in SH-SY5Y cells. Such mRNA imaging agents with near-infrared fluorophores might enable real time imaging and quantitation of neuronal mRNAs in live animal models.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22239616      PMCID: PMC3288683          DOI: 10.1021/bc2004507

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  31 in total

1.  Association between bipolar disorder and monoamine oxidase A gene polymorphisms: results of a multicenter study.

Authors:  M Preisig; F Bellivier; B T Fenton; P Baud; A Berney; P Courtet; P Hardy; J Golaz; M Leboyer; J Mallet; M L Matthey; D Mouthon; E Neidhart; M Nosten-Bertrand; E Stadelmann-Dubuis; J Guimon; F Ferrero; C Buresi; A Malafosse
Journal:  Am J Psychiatry       Date:  2000-06       Impact factor: 18.112

2.  Linkage studies between attention-deficit hyperactivity disorder and the monoamine oxidase genes.

Authors:  S Jiang; R Xin; S Lin; Y Qian; G Tang; D Wang; X Wu
Journal:  Am J Med Genet       Date:  2001-12-08

3.  A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity.

Authors:  S B Manuck; J D Flory; R E Ferrell; J J Mann; M F Muldoon
Journal:  Psychiatry Res       Date:  2000-07-24       Impact factor: 3.222

4.  Substance-specific and shared transcription and epigenetic changes in the human hippocampus chronically exposed to cocaine and alcohol.

Authors:  Zhifeng Zhou; Qiaoping Yuan; Deborah C Mash; David Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

5.  Gene-gene interaction between the monoamine oxidase A gene and solute carrier family 6 (neurotransmitter transporter, noradrenalin) member 2 gene in anorexia nervosa (restrictive subtype).

Authors:  Ruth E Urwin; Bruce H Bennetts; Bridget Wilcken; Basiliki Lampropoulos; Peter J V Beumont; Janice D Russell; Sue L Tanner; Kenneth P Nunn
Journal:  Eur J Hum Genet       Date:  2003-12       Impact factor: 4.246

6.  Association of monoamine oxidase A gene polymorphism with Alzheimer's disease and Lewy body variant.

Authors:  Masanori Takehashi; Seigo Tanaka; Eliezer Masliah; Kunihiro Ueda
Journal:  Neurosci Lett       Date:  2002-07-19       Impact factor: 3.046

7.  Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression.

Authors:  A Tadic; D Rujescu; A Szegedi; I Giegling; P Singer; H-J Möller; N Dahmen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-02       Impact factor: 3.568

8.  Association analysis of monoamine oxidase A and attention deficit hyperactivity disorder.

Authors:  Deborah C Lawson; Darko Turic; Kate Langley; Helen M Pay; Catherine F Govan; Nadine Norton; Marian L Hamshere; Michael J Owen; Michael C O'Donovan; Anita Thapar
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-01-01       Impact factor: 3.568

9.  Haplotypes of the monoamine oxidase genes and the risk for substance use disorders.

Authors:  Michael M Vanyukov; Brion S Maher; Bernie Devlin; Ralph E Tarter; Galina P Kirillova; Ling-Mei Yu; Robert E Ferrell
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2004-02-15       Impact factor: 3.568

10.  An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences.

Authors:  Yung-Yu Huang; Sarah P Cate; Cristina Battistuzzi; Maria A Oquendo; David Brent; J John Mann
Journal:  Neuropsychopharmacology       Date:  2004-08       Impact factor: 7.853

View more
  9 in total

1.  Conjugation with receptor-targeted histidine-rich peptides enhances the pharmacological effectiveness of antisense oligonucleotides.

Authors:  Osamu Nakagawa; Xin Ming; Kyle Carver; Rudy Juliano
Journal:  Bioconjug Chem       Date:  2013-12-19       Impact factor: 4.774

Review 2.  Cellular uptake and intracellular trafficking of oligonucleotides.

Authors:  R L Juliano; K Carver
Journal:  Adv Drug Deliv Rev       Date:  2015-04-14       Impact factor: 15.470

Review 3.  DNA and RNA derivatives to optimize distribution and delivery.

Authors:  Eric Wickstrom
Journal:  Adv Drug Deliv Rev       Date:  2015-04-22       Impact factor: 15.470

4.  Covalent conjugation of oligonucleotides with cell-targeting ligands.

Authors:  Md Rowshon Alam; Xin Ming; Osamu Nakagawa; Jian Jin; R L Juliano
Journal:  Bioorg Med Chem       Date:  2013-06-01       Impact factor: 3.641

5.  Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221.

Authors:  Eleonora Brognara; Enrica Fabbri; Elena Bazzoli; Giulia Montagner; Claudio Ghimenton; Albino Eccher; Cinzia Cantù; Alex Manicardi; Nicoletta Bianchi; Alessia Finotti; Giulia Breveglieri; Monica Borgatti; Roberto Corradini; Valentino Bezzerri; Giulio Cabrini; Roberto Gambari
Journal:  J Neurooncol       Date:  2014-03-05       Impact factor: 4.130

6.  High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides.

Authors:  B Yang; X Ming; C Cao; B Laing; A Yuan; M A Porter; E A Hull-Ryde; J Maddry; M Suto; W P Janzen; R L Juliano
Journal:  Nucleic Acids Res       Date:  2015-02-06       Impact factor: 16.971

7.  Design of a multicomponent peptide-woven nanocomplex for delivery of siRNA.

Authors:  Eunsung Jun; Soyoun Kim; Jong-Ho Kim; Kiweon Cha; In-Seop So; Hye-Nam Son; Byung-Heon Lee; Kwangmeyung Kim; Ick Chan Kwon; Sang Yoon Kim; In-San Kim
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

8.  Fluorescence detection of KRAS2 mRNA hybridization in lung cancer cells with PNA-peptides containing an internal thiazole orange.

Authors:  Mahesh V Sonar; Matthew E Wampole; Yuan-Yuan Jin; Chang-Po Chen; Mathew L Thakur; Eric Wickstrom
Journal:  Bioconjug Chem       Date:  2014-09-02       Impact factor: 4.774

9.  The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides.

Authors:  Xin Ming; Kyle Carver; Michael Fisher; Romain Noel; Jean-Christophe Cintrat; Daniel Gillet; Julien Barbier; Canhong Cao; John Bauman; Rudolph L Juliano
Journal:  Nucleic Acids Res       Date:  2013-02-08       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.